Loading clinical trials...
Loading clinical trials...
The purpose of the study was to measure the safety and efficacy of a 12-week flexible dosing strategy of CP-526,555 compared with placebo for smoking cessation. Post-treatment follow-up of smoking sta...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT05628389 · Smoking Cessation
NCT06948058 · Smoking Cessation, Obesity and Obesity-related Medical Conditions
NCT06820034 · Smoking Cessation
NCT07129590 · Smoking Cessation, Tobacco Smoking, and more
NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation
Pfizer Investigational Site
Lexington, Kentucky
Pfizer Investigational Site
Albert Lea, Minnesota
Pfizer Investigational Site
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions